USPH vs. PRVA, PNTG, INNV, LFST, WGS, TALK, TARO, KURA, ADMA, and VCYT
Should you be buying U.S. Physical Therapy stock or one of its competitors? The main competitors of U.S. Physical Therapy include Privia Health Group (PRVA), The Pennant Group (PNTG), InnovAge (INNV), LifeStance Health Group (LFST), GeneDx (WGS), Talkspace (TALK), Taro Pharmaceutical Industries (TARO), Kura Oncology (KURA), ADMA Biologics (ADMA), and Veracyte (VCYT). These companies are all part of the "medical" sector.
U.S. Physical Therapy (NYSE:USPH) and Privia Health Group (NASDAQ:PRVA) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, community ranking, profitability, valuation and dividends.
In the previous week, Privia Health Group had 5 more articles in the media than U.S. Physical Therapy. MarketBeat recorded 24 mentions for Privia Health Group and 19 mentions for U.S. Physical Therapy. U.S. Physical Therapy's average media sentiment score of 0.67 beat Privia Health Group's score of 0.03 indicating that U.S. Physical Therapy is being referred to more favorably in the media.
U.S. Physical Therapy received 192 more outperform votes than Privia Health Group when rated by MarketBeat users. However, 73.33% of users gave Privia Health Group an outperform vote while only 56.14% of users gave U.S. Physical Therapy an outperform vote.
U.S. Physical Therapy has higher earnings, but lower revenue than Privia Health Group. U.S. Physical Therapy is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.
U.S. Physical Therapy has a beta of 1.39, meaning that its share price is 39% more volatile than the S&P 500. Comparatively, Privia Health Group has a beta of 0.81, meaning that its share price is 19% less volatile than the S&P 500.
94.5% of Privia Health Group shares are owned by institutional investors. 1.7% of U.S. Physical Therapy shares are owned by insiders. Comparatively, 14.2% of Privia Health Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
U.S. Physical Therapy has a net margin of 4.72% compared to Privia Health Group's net margin of 1.11%. U.S. Physical Therapy's return on equity of 8.03% beat Privia Health Group's return on equity.
U.S. Physical Therapy presently has a consensus target price of $125.67, suggesting a potential upside of 17.75%. Privia Health Group has a consensus target price of $25.33, suggesting a potential upside of 49.90%. Given Privia Health Group's higher possible upside, analysts clearly believe Privia Health Group is more favorable than U.S. Physical Therapy.
Summary
U.S. Physical Therapy beats Privia Health Group on 10 of the 18 factors compared between the two stocks.
Get U.S. Physical Therapy News Delivered to You Automatically
Sign up to receive the latest news and ratings for USPH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding USPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
U.S. Physical Therapy Competitors List
Related Companies and Tools
